Increasing the proportion of this in my portfolio

$SBC Medical Group (SBC.US)$ Although SBC’s stock performance has faced challenges, the company’s consistent revenue growth and strategic expansions demonstrate resilience. Hence, we can consider its long-term potential as demand for medical aesthetics continues to grow globally.